Li-Qiang Zhou
Overview
Explore the profile of Li-Qiang Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
822
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou L, Liu W
Sci Rep
. 2024 Jul;
14(1):17759.
PMID: 39085336
This study aimed to evaluate arsenic (As), cadmium (Cd), chromium (Cr), and lead (Pb) levels in dried chili peppers from nine districts in Guizhou Province. These heavy metals, widely dispersed...
2.
Hu Y, Zhang L, Wen Q, Cheng X, Zhou L, Chen M, et al.
Int J Biol Macromol
. 2024 Jun;
273(Pt 2):133045.
PMID: 38942666
This work was to investigate the effect of four prebiotic saccharides gum arabic (GA), fructooligosaccharide (FOS), konjac glucomannan (KGM), and inulin (INU) incorporation on the encapsulation efficiency (EE), physicochemical stability,...
3.
Zhou L, Wu X, Huang S, Wu G, Ye H, Wei Q, et al.
Radiology
. 2024 Mar;
310(3):e249009.
PMID: 38530188
No abstract available.
4.
Zhou L, Zeng S, Xu J, Lv W, Mei D, Tu J, et al.
Insights Imaging
. 2023 Dec;
14(1):222.
PMID: 38117404
Objectives: Precise determination of cervical lymph node metastasis (CLNM) involvement in patients with early-stage thyroid cancer is fairly significant for identifying appropriate cervical treatment options. However, it is almost impossible...
5.
Tang C, Zhang H, Deng W, Xiong L, Zhou L
Kaohsiung J Med Sci
. 2023 Jun;
39(9):904-915.
PMID: 37334727
Cancer stem cells (CSCs), a rare subset of tumor cells, have been recognized as promotive role on tumor initiation and propagation. Among, aerobic glycolysis, widely clarified in multiple tumor cells,...
6.
Chen H, Tao Y, Zhou Y, Zhong Q, Zhou L, Shi Y
Curr Med Sci
. 2022 Dec;
42(6):1220-1230.
PMID: 36547871
Objective: Due to the rarity of angioimmunoblastic T-cell lymphoma (AITL), very limited data concerning its incidence patterns and prognostic factors are available. This study aimed to explore the incidence, characteristics,...
7.
Li H, Wang S, Xu H, Yan X, Zhang J, Lei S, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358728
(1) Background: Afatinib has been approved for patients with non-small cell lung cancer (NSCLC) carrying major uncommon epidermal growth factor receptor gene () mutations. Dacomitinib, another second-generation tyrosine kinase inhibitor,...
8.
Li H, Yang G, Cai Y, Li J, Xu H, Zhang T, et al.
Front Pharmacol
. 2022 Jun;
13:919652.
PMID: 35770100
Dacomitinib has been approved for non-small-cell lung cancer (NSCLC) patients harboring classical epidermal growth factor receptor () mutations; however, clinical evidence of its activity on major uncommon mutations is currently...
9.
Li H, Li J, Yan X, Xu H, Zhou L, Hu X, et al.
J Thorac Dis
. 2022 Jun;
14(5):1428-1440.
PMID: 35693621
Background: Dacomitinib is a first-line treatment for patients with non-small cell lung cancer (NSCLC) harboring common epidermal growth factor receptor () mutations; however, clinical evidence of its activity on NSCLC...
10.
Zhou L, Liu C, Zou Y, Chen Z
Sci Rep
. 2022 May;
12(1):8908.
PMID: 35618744
Dilated cardiomyopathy (DCM) is a primary myocardial disease of unclear mechanism and poor prevention. The purpose of this study is to explore the potential molecular mechanisms and targets of DCM...